| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Hypothermia | D007035 | 19 associated lipids |
Total
3
noladin ether
Noladin ether is a lipid of Glycerolipids (GL) class. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity and Competitive inhibition. Noladin ether often locates in Synaptosomes and Tissue membrane. The associated genes with Noladin Ether are IMPACT gene. The related lipids are noladin ether and Fatty Alcohols.
Cross Reference
Introduction
To understand associated biological information of noladin ether, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with noladin ether?
There are no associated biomedical information in the current reference collection.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with noladin ether
PubChem Associated disorders and diseases
What pathways are associated with noladin ether
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with noladin ether?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with noladin ether?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with noladin ether?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with noladin ether?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with noladin ether?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with noladin ether
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Juntunen J et al. | Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether. | 2003 | J. Med. Chem. | pmid:14584958 |
| Oka S et al. | Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. | 2003 | J. Neurochem. | pmid:12787057 |
| Shoemaker JL et al. | Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. | 2005 | J. Pharmacol. Exp. Ther. | pmid:16081674 |
| Shoemaker JL et al. | The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15901805 |
| Shimizu T et al. | Stimulatory and inhibitory roles of brain 2-arachidonoylglycerol in bombesin-induced central activation of adrenomedullary outflow in rats. | 2013 | J. Pharmacol. Sci. | pmid:23386378 |
| Straiker A and Mackie K | Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. | 2005 | J. Physiol. (Lond.) | pmid:16179366 |
| van der Stelt M et al. | Acute neuronal injury, excitotoxicity, and the endocannabinoid system. | 2002 Oct-Dec | Mol. Neurobiol. | pmid:12428763 |
| Guo J and Ikeda SR | Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. | 2004 | Mol. Pharmacol. | pmid:14978245 |
| Kumar A and Song ZH | CB1 cannabinoid receptor-mediated changes of trabecular meshwork cellular properties. | 2006 | Mol. Vis. | pmid:16617296 |
| Páldy E et al. | CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain. | 2008 | Neurochem. Int. | pmid:18804501 |